| 000 | 01888 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250514230256.0 | ||
| 264 | 0 | _c20060221 | |
| 008 | 200602s 0 0 eng d | ||
| 022 | _a1471-2369 | ||
| 024 | 7 |
_a10.1186/1471-2369-6-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPérez-Oliva, Jorge F | |
| 245 | 0 | 0 |
_aComparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study. _h[electronic resource] |
| 260 |
_bBMC nephrology _cMay 2005 |
||
| 300 |
_a5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnemia _xdrug therapy |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEpoetin Alfa |
| 650 | 0 | 4 |
_aErythropoietin _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHematinics _xadverse effects |
| 650 | 0 | 4 | _aHematocrit |
| 650 | 0 | 4 |
_aHemoglobins _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xtherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aCasanova-González, Martha | |
| 700 | 1 | _aGarcía-García, Idrian | |
| 700 | 1 | _aPorrero-Martín, Pedro J | |
| 700 | 1 | _aValenzuela-Silva, Carmen M | |
| 700 | 1 | _aHernández-Montero, Tairí | |
| 700 | 1 | _aLagarde-Ampudia, Marcia | |
| 700 | 1 | _aCasanova-Kutsareva, Yuri | |
| 700 | 1 | _aAvila-Albuerne, Yisel | |
| 700 | 1 | _aVargas-Batista, Alicia | |
| 700 | 1 | _aBobillo-López, Hailen | |
| 700 | 1 | _aHerrera-Valdés, Raúl | |
| 700 | 1 | _aLópez-Saura, Pedro A | |
| 773 | 0 |
_tBMC nephrology _gvol. 6 _gp. 5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2369-6-5 _zAvailable from publisher's website |
| 999 |
_c15572480 _d15572480 |
||